Ranbaxy Company Cyber Security Posture
ranbaxy.comRanbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranked 8th amongst the global generic pharmaceutical companies, Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The Company has a global footprint in 49 countries, world-class manufacturing facilities in 11 countries and serves customers in over 125 countries. In June 2008, Ranbaxy entered into an alliance with one of the largest Japanese innovator companies, Daiichi Sankyo Company Ltd., to create an innovator and generic pharmaceutical powerhouse. The combined entity now ranks among the top 15 pharmaceutical companies, globally. The transformational deal will place Ranbaxy in a higher growth trajectory and it will emerge stronger in terms of its global reach and in its capabilities in drug development and manufacturing. Vision & Aspirations Ranbaxy is driven by its vision to achieve significant business in proprietary prescription products by 2012 with a strong presence in developed markets. The Company aspires to be amongst the Top 5 global generic players and aims at achieving global sales of US $5 Bn by 2012. Financials Ranbaxy was incorporated in 1961 and went public in 1973. For the year 2008, the Company recorded Global Sales of US $ 1,682 Mn, reflecting a growth of 4%. The Company has a balanced mix of revenues from emerging and developed markets that contribute 54% and 39% respectively. In 2008, North America, the Company's largest market contributed sales of US $ 449 Mn, followed by Europe garnering US $ 330 Mn. Business in Asia has been going strong with India clocking sales of around US $ 300 Mn with market leadership in several business segments, backed by strong brand-building skills.
Ranbaxy Company Details
ranbaxy
10,001+ employees
88847
325
Pharmaceutical Manufacturing
ranbaxy.com
Scan still pending
RAN_1850032
In-progress
Ranbaxy Risk Score (AI oriented)Between 800 and 900
This score is AI-generated and less favored by cyber insurers, who prefer the TPRM score.
Ranbaxy Global Score.png)
Ranbaxy Company Scoring based on AI Models
| Model Name | Date | Description | Current Score Difference | Score |
|---|---|---|---|---|
| AVERAGE-Industry | 03-12-2025 | This score represents the average cybersecurity rating of companies already scanned within the same industry. It provides a benchmark to compare an individual company's security posture against its industry peers. | N/A | Between 800 and 900 |
Ranbaxy Company Cyber Security News & History
| Entity | Type | Severity | Impact | Seen | Url ID | Details | View |
|---|
Ranbaxy Company Subsidiaries
Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranked 8th amongst the global generic pharmaceutical companies, Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The Company has a global footprint in 49 countries, world-class manufacturing facilities in 11 countries and serves customers in over 125 countries. In June 2008, Ranbaxy entered into an alliance with one of the largest Japanese innovator companies, Daiichi Sankyo Company Ltd., to create an innovator and generic pharmaceutical powerhouse. The combined entity now ranks among the top 15 pharmaceutical companies, globally. The transformational deal will place Ranbaxy in a higher growth trajectory and it will emerge stronger in terms of its global reach and in its capabilities in drug development and manufacturing. Vision & Aspirations Ranbaxy is driven by its vision to achieve significant business in proprietary prescription products by 2012 with a strong presence in developed markets. The Company aspires to be amongst the Top 5 global generic players and aims at achieving global sales of US $5 Bn by 2012. Financials Ranbaxy was incorporated in 1961 and went public in 1973. For the year 2008, the Company recorded Global Sales of US $ 1,682 Mn, reflecting a growth of 4%. The Company has a balanced mix of revenues from emerging and developed markets that contribute 54% and 39% respectively. In 2008, North America, the Company's largest market contributed sales of US $ 449 Mn, followed by Europe garnering US $ 330 Mn. Business in Asia has been going strong with India clocking sales of around US $ 300 Mn with market leadership in several business segments, backed by strong brand-building skills.
Access Data Using Our API
Get company history
Rapid.png)
Ranbaxy Cyber Security News
From Tycoon to Bankrupt: The Fall of Fortis and Religare Promoter Shivinder Mohan Singh
Shivinder Mohan Singh, once a towering figure in India's healthcare and financial services sectors, has filed for personal insolvency before ...
Veteran Security Operations Strategist, Amrit Sethi Joins Adani as Group Head for Cyber Security
Veteran cybersecurity advisor and Associate Partner at KPMG, Amrit Sethi has been appointed as the Group Head for Cyber Security at the Adani Group.
India's Role In Cybersecurity Collaboration With G20
Rated among India's Best IT leaders, Sujoy Brahmachari has received numerous awards, including Best CISO, Technology Evangelist, and Prominent CIO/CTO.
Hero MotoCorp's CIO & CHRO Vijay Sethi quits
“I am writing to inform you that Vijay Sethi has left the organization, effective January 22, 2021 after 13 years of service,” Pawan Munjal in internal staff ...
Ranbaxy Similar Companies
CVS Pharmacy
CVS Pharmacy is America’s leading retail pharmacy with more than 9,600 locations nationwide. For more than 50 years, CVS Pharmacy has offered customers the products and services they need to stay on their path to better health. In addition to our pharmacies, our stores feature on-trend beauty depart
Alembic Pharmaceuticals Limited
Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrol
Zydus Group
The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worl
Takeda
We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by list
Merck KGaA, Darmstadt, Germany
We are Merck KGaA, Darmstadt, Germany and its global affiliates. We are a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to e
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating wit
Frequently Asked Questions (FAQ) on Cybersecurity Incidents
Ranbaxy CyberSecurity History Information
Total Incidents: According to Rankiteo, Ranbaxy has faced 0 incidents in the past.
Incident Types: As of the current reporting period, Ranbaxy has not encountered any cybersecurity incidents.
Total Financial Loss: The total financial loss from these incidents is estimated to be {total_financial_loss}.
Cybersecurity Posture: The company's overall cybersecurity posture is described as Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranked 8th amongst the global generic pharmaceutical companies, Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The Company has a global footprint in 49 countries, world-class manufacturing facilities in 11 countries and serves customers in over 125 countries. In June 2008, Ranbaxy entered into an alliance with one of the largest Japanese innovator companies, Daiichi Sankyo Company Ltd., to create an innovator and generic pharmaceutical powerhouse. The combined entity now ranks among the top 15 pharmaceutical companies, globally. The transformational deal will place Ranbaxy in a higher growth trajectory and it will emerge stronger in terms of its global reach and in its capabilities in drug development and manufacturing. Vision & Aspirations Ranbaxy is driven by its vision to achieve significant business in proprietary prescription products by 2012 with a strong presence in developed markets. The Company aspires to be amongst the Top 5 global generic players and aims at achieving global sales of US $5 Bn by 2012. Financials Ranbaxy was incorporated in 1961 and went public in 1973. For the year 2008, the Company recorded Global Sales of US $ 1,682 Mn, reflecting a growth of 4%. The Company has a balanced mix of revenues from emerging and developed markets that contribute 54% and 39% respectively. In 2008, North America, the Company's largest market contributed sales of US $ 449 Mn, followed by Europe garnering US $ 330 Mn. Business in Asia has been going strong with India clocking sales of around US $ 300 Mn with market leadership in several business segments, backed by strong brand-building skills..
Detection and Response: The company detects and responds to cybersecurity incidents through {description_of_detection_and_response_process}.
Incident Details
Incident 1: Ransomware Attack
Title: {Incident_Title}
Description: {Brief_description_of_the_incident}
Date Detected: {Detection_Date}
Date Publicly Disclosed: {Disclosure_Date}
Date Resolved: {Resolution_Date}
Type: {Type_of_Attack}
Attack Vector: {Attack_Vector}
Vulnerability Exploited: {Vulnerability}
Threat Actor: {Threat_Actor}
Motivation: {Motivation}
Incident 2: Data Breach
Title: {Incident_Title}
Description: {Brief_description_of_the_incident}
Date Detected: {Detection_Date}
Date Publicly Disclosed: {Disclosure_Date}
Date Resolved: {Resolution_Date}
Type: {Type_of_Attack}
Attack Vector: {Attack_Vector}
Vulnerability Exploited: {Vulnerability}
Threat Actor: {Threat_Actor}
Motivation: {Motivation}
Common Attack Types: As of now, the company has not encountered any reported incidents involving common cyberattacks.
Identification of Attack Vectors: The company identifies the attack vectors used in incidents through {description_of_identification_process}.
Impact of the Incidents
Incident 1: Ransomware Attack
Financial Loss: {Financial_Loss}
Data Compromised: {Data_Compromised}
Systems Affected: {Systems_Affected}
Downtime: {Downtime}
Operational Impact: {Operational_Impact}
Conversion Rate Impact: {Conversion_Rate_Impact}
Revenue Loss: {Revenue_Loss}
Customer Complaints: {Customer_Complaints}
Brand Reputation Impact: {Brand_Reputation_Impact}
Legal Liabilities: {Legal_Liabilities}
Identity Theft Risk: {Identity_Theft_Risk}
Payment Information Risk: {Payment_Information_Risk}
Incident 2: Data Breach
Financial Loss: {Financial_Loss}
Data Compromised: {Data_Compromised}
Systems Affected: {Systems_Affected}
Downtime: {Downtime}
Operational Impact: {Operational_Impact}
Conversion Rate Impact: {Conversion_Rate_Impact}
Revenue Loss: {Revenue_Loss}
Customer Complaints: {Customer_Complaints}
Brand Reputation Impact: {Brand_Reputation_Impact}
Legal Liabilities: {Legal_Liabilities}
Identity Theft Risk: {Identity_Theft_Risk}
Payment Information Risk: {Payment_Information_Risk}
Average Financial Loss: The average financial loss per incident is {average_financial_loss}.
Commonly Compromised Data Types: The types of data most commonly compromised in incidents are {list_of_commonly_compromised_data_types}.
Incident 1: Ransomware Attack
Entity Name: {Entity_Name}
Entity Type: {Entity_Type}
Industry: {Industry}
Location: {Location}
Size: {Size}
Customers Affected: {Customers_Affected}
Incident 2: Data Breach
Entity Name: {Entity_Name}
Entity Type: {Entity_Type}
Industry: {Industry}
Location: {Location}
Size: {Size}
Customers Affected: {Customers_Affected}
Response to the Incidents
Incident 1: Ransomware Attack
Incident Response Plan Activated: {Yes/No}
Third Party Assistance: {Yes/No}
Law Enforcement Notified: {Yes/No}
Containment Measures: {Containment_Measures}
Remediation Measures: {Remediation_Measures}
Recovery Measures: {Recovery_Measures}
Communication Strategy: {Communication_Strategy}
Adaptive Behavioral WAF: {Adaptive_Behavioral_WAF}
On-Demand Scrubbing Services: {On_Demand_Scrubbing_Services}
Network Segmentation: {Network_Segmentation}
Enhanced Monitoring: {Enhanced_Monitoring}
Incident 2: Data Breach
Incident Response Plan Activated: {Yes/No}
Third Party Assistance: {Yes/No}
Law Enforcement Notified: {Yes/No}
Containment Measures: {Containment_Measures}
Remediation Measures: {Remediation_Measures}
Recovery Measures: {Recovery_Measures}
Communication Strategy: {Communication_Strategy}
Adaptive Behavioral WAF: {Adaptive_Behavioral_WAF}
On-Demand Scrubbing Services: {On_Demand_Scrubbing_Services}
Network Segmentation: {Network_Segmentation}
Enhanced Monitoring: {Enhanced_Monitoring}
Incident Response Plan: The company's incident response plan is described as {description_of_incident_response_plan}.
Third-Party Assistance: The company involves third-party assistance in incident response through {description_of_third_party_involvement}.
Data Breach Information
Incident 2: Data Breach
Type of Data Compromised: {Type_of_Data}
Number of Records Exposed: {Number_of_Records}
Sensitivity of Data: {Sensitivity_of_Data}
Data Exfiltration: {Yes/No}
Data Encryption: {Yes/No}
File Types Exposed: {File_Types}
Personally Identifiable Information: {Yes/No}
Prevention of Data Exfiltration: The company takes the following measures to prevent data exfiltration: {description_of_prevention_measures}.
Handling of PII Incidents: The company handles incidents involving personally identifiable information (PII) through {description_of_handling_process}.
Ransomware Information
Incident 1: Ransomware Attack
Ransom Demanded: {Ransom_Amount}
Ransom Paid: {Ransom_Paid}
Ransomware Strain: {Ransomware_Strain}
Data Encryption: {Yes/No}
Data Exfiltration: {Yes/No}
Ransom Payment Policy: The company's policy on paying ransoms in ransomware incidents is described as {description_of_ransom_payment_policy}.
Data Recovery from Ransomware: The company recovers data encrypted by ransomware through {description_of_data_recovery_process}.
Regulatory Compliance
Incident 1: Ransomware Attack
Regulations Violated: {Regulations_Violated}
Fines Imposed: {Fines_Imposed}
Legal Actions: {Legal_Actions}
Regulatory Notifications: {Regulatory_Notifications}
Incident 2: Data Breach
Regulations Violated: {Regulations_Violated}
Fines Imposed: {Fines_Imposed}
Legal Actions: {Legal_Actions}
Regulatory Notifications: {Regulatory_Notifications}
Regulatory Frameworks: The company complies with the following regulatory frameworks regarding cybersecurity: {list_of_regulatory_frameworks}.
Ensuring Regulatory Compliance: The company ensures compliance with regulatory requirements through {description_of_compliance_measures}.
Lessons Learned and Recommendations
Incident 1: Ransomware Attack
Lessons Learned: {Lessons_Learned}
Incident 2: Data Breach
Lessons Learned: {Lessons_Learned}
Incident 1: Ransomware Attack
Recommendations: {Recommendations}
Incident 2: Data Breach
Recommendations: {Recommendations}
Key Lessons Learned: The key lessons learned from past incidents are {list_of_key_lessons_learned}.
Implemented Recommendations: The company has implemented the following recommendations to improve cybersecurity: {list_of_implemented_recommendations}.
References
Additional Resources: Stakeholders can find additional resources on cybersecurity best practices at {list_of_additional_resources}.
Investigation Status
Incident 1: Ransomware Attack
Investigation Status: {Investigation_Status}
Incident 2: Data Breach
Investigation Status: {Investigation_Status}
Communication of Investigation Status: The company communicates the status of incident investigations to stakeholders through {description_of_communication_process}.
Stakeholder and Customer Advisories
Incident 1: Ransomware Attack
Stakeholder Advisories: {Stakeholder_Advisories}
Customer Advisories: {Customer_Advisories}
Incident 2: Data Breach
Stakeholder Advisories: {Stakeholder_Advisories}
Customer Advisories: {Customer_Advisories}
Advisories Provided: The company provides the following advisories to stakeholders and customers following an incident: {description_of_advisories_provided}.
Initial Access Broker
Incident 1: Ransomware Attack
Entry Point: {Entry_Point}
Reconnaissance Period: {Reconnaissance_Period}
Backdoors Established: {Backdoors_Established}
High Value Targets: {High_Value_Targets}
Data Sold on Dark Web: {Yes/No}
Incident 2: Data Breach
Entry Point: {Entry_Point}
Reconnaissance Period: {Reconnaissance_Period}
Backdoors Established: {Backdoors_Established}
High Value Targets: {High_Value_Targets}
Data Sold on Dark Web: {Yes/No}
Monitoring and Mitigation of Initial Access Brokers: The company monitors and mitigates the activities of initial access brokers through {description_of_monitoring_and_mitigation_measures}.
Post-Incident Analysis
Incident 1: Ransomware Attack
Root Causes: {Root_Causes}
Corrective Actions: {Corrective_Actions}
Incident 2: Data Breach
Root Causes: {Root_Causes}
Corrective Actions: {Corrective_Actions}
Post-Incident Analysis Process: The company's process for conducting post-incident analysis is described as {description_of_post_incident_analysis_process}.
Corrective Actions Taken: The company has taken the following corrective actions based on post-incident analysis: {list_of_corrective_actions_taken}.
Additional Questions
General Information
Ransom Payment History: The company has {paid/not_paid} ransoms in the past.
Last Ransom Demanded: The amount of the last ransom demanded was {last_ransom_amount}.
Last Attacking Group: The attacking group in the last incident was {last_attacking_group}.
Incident Details
Most Recent Incident Detected: The most recent incident detected was on {most_recent_incident_detected_date}.
Most Recent Incident Publicly Disclosed: The most recent incident publicly disclosed was on {most_recent_incident_publicly_disclosed_date}.
Most Recent Incident Resolved: The most recent incident resolved was on {most_recent_incident_resolved_date}.
Impact of the Incidents
Highest Financial Loss: The highest financial loss from an incident was {highest_financial_loss}.
Most Significant Data Compromised: The most significant data compromised in an incident was {most_significant_data_compromised}.
Most Significant System Affected: The most significant system affected in an incident was {most_significant_system_affected}.
Response to the Incidents
Third-Party Assistance in Most Recent Incident: The third-party assistance involved in the most recent incident was {third_party_assistance_in_most_recent_incident}.
Containment Measures in Most Recent Incident: The containment measures taken in the most recent incident were {containment_measures_in_most_recent_incident}.
Data Breach Information
Most Sensitive Data Compromised: The most sensitive data compromised in a breach was {most_sensitive_data_compromised}.
Number of Records Exposed: The number of records exposed in the most significant breach was {number_of_records_exposed}.
Ransomware Information
Highest Ransom Demanded: The highest ransom demanded in a ransomware incident was {highest_ransom_demanded}.
Highest Ransom Paid: The highest ransom paid in a ransomware incident was {highest_ransom_paid}.
Regulatory Compliance
Highest Fine Imposed: The highest fine imposed for a regulatory violation was {highest_fine_imposed}.
Most Significant Legal Action: The most significant legal action taken for a regulatory violation was {most_significant_legal_action}.
Lessons Learned and Recommendations
Most Significant Lesson Learned: The most significant lesson learned from past incidents was {most_significant_lesson_learned}.
Most Significant Recommendation Implemented: The most significant recommendation implemented to improve cybersecurity was {most_significant_recommendation_implemented}.
References
Most Recent Source: The most recent source of information about an incident is {most_recent_source}.
Most Recent URL for Additional Resources: The most recent URL for additional resources on cybersecurity best practices is {most_recent_url}.
Investigation Status
Current Status of Most Recent Investigation: The current status of the most recent investigation is {current_status_of_most_recent_investigation}.
Stakeholder and Customer Advisories
Most Recent Stakeholder Advisory: The most recent stakeholder advisory issued was {most_recent_stakeholder_advisory}.
Most Recent Customer Advisory: The most recent customer advisory issued was {most_recent_customer_advisory}.
Initial Access Broker
Most Recent Entry Point: The most recent entry point used by an initial access broker was {most_recent_entry_point}.
Most Recent Reconnaissance Period: The most recent reconnaissance period for an incident was {most_recent_reconnaissance_period}.
Post-Incident Analysis
Most Significant Root Cause: The most significant root cause identified in post-incident analysis was {most_significant_root_cause}.
Most Significant Corrective Action: The most significant corrective action taken based on post-incident analysis was {most_significant_corrective_action}.
What Do We Measure?
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
